Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Shares of PTC Therapeutics fell after the company said regulators for the European Union won't renew authorization for its Translarna treatment for nonsense mutation Duchenne muscular dystrophy.

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

POOR PIERRE — Mere months ago, the Conservative Party in Canada looked headed towards a landslide victory. Its leader, Pierre Poilievre, was ascendant and drawing rave reviews from much of the ...

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Australia is considering a World Trade Organisation challenge against US President Donald Trump’s steel and aluminium tariffs ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Most of that damage has come since President Trump’s inauguration on Jan. 20—the stock lost 38% of its value between then and last week’s close, even before the bruising selloff on Monday.

However, the stock was also likely negatively impacted by CNBC Mad Money host Jim Cramer's comments on Friday. He expressed reservations about buying shares of Recursion Pharmaceuticals in light ...

This top company remains a solid pharmaceutical stock to own long-term, offering an outstanding entry point and a massive 4.15% dividend. Bristol-Myers Squibb Co. (NYSE: BMY) discovers ...